Talking Medicines gives Pharma and agencies the intelligence to predict and prove HCP messaging impact, closing the $23Bn blind spot.
Talking Medicines has raised $364K in total funding. The most recent round was Convertible Note. The last funding was announced in May 2026.
Talking Medicines's investors include Scottish Enterprise, SIS Ventures, Tern, Rob Dobson, Mark Bamforth.
Talking Medicines is headquartered in Glasgow, United Kingdom.
Talking Medicines gives Pharma and agencies the intelligence to predict and prove HCP messaging impact, closing the $23Bn blind spot.
Talking Medicines is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Talking Medicines — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/talking-medicines. Accessed August 1, 2026.
VCBacked. (2026). Talking Medicines — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/talking-medicines
{{cite web |title=Talking Medicines — Funding & Investors |url=https://www.vcbacked.co/company/talking-medicines |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated